baber/WOPTO huggingface dataset:
Patent NZ-547544-A (NZ)
Title: Container tilting apparatus
Inventor: WARD SIMON ROBERT
Filed: 2006-05-26
Abstract: A freight container tilting facility includes a base, a pair of tilt arms separated by the width of a container and each pivotable on the base, and a drive to tilt the arms from about the horizontal to the vertical. A truck carrying a container can be backed in between the arms whilst they are slightly tilted upwards, and the "bottom" end of the arms engaged with the rear end locks on the sides of the container. The arms are then tilted down toward the horizontal so that the "top" ends of the arms can be engaged with the front end locks on the sides of the container. The arms, with container attached, can then be tilted to the vertical position so that material can be loaded into the container high end or "poured" from the container low end. The pivot point of the arms on the base is higher above the base than the length of the "bottom" portion of the arms to provide adequate tilting clearance.
Patent NZ-547803-A (NZ)
Title: Composition for topical use containing an extract of stryphnodendron, its preparation as well as its application
Inventor: CASTRO FRANCA SUZELEI DE
IPC: A61K36/00
Filed: 2004-11-11
Abstract: Disclosed is a topical composition containing a Stryphnodendron genus plant extract wherein said composition contains an amount from 2% to 5% (w/w) of total phenols. Also disclosed is a process for said topical composition, a use of said composition in the manufacture of a topical composition for the treatment of cutaneous wounds and a method of treating cutaneous wounds in a non-human subject comprising administering said composition.
Patent NZ-553155-A (NZ)
Title: Pattern-cutting device with integral base and shaped blade, manufacture method and mould thereof
Inventor: DENG YEQING
IPC: B22D17/22
Filed: 2005-07-18
Abstract: A manufacture method for manufacturing a pattern cutting device having a base and a blade, the blade located on the base and shaped into a pattern to be cut with the blade, comprising forming the base and blade as an integral structure at one time through a die cast process which includes the steps of placing a die cast mould on a die cast machine and using the die cast machine to inject a molten alloy fluid into a mould cavity of the die cast mould at a pressure of about 25 to 40 MPa, removing a die cast part from the die cast mould after cooling and shaping, and plating the die cast part to harden the surface of the blade of the die cast part.
Patent NZ-554632-A (NZ)
Title: microCHP with emergency power supply for continutation of a shut down system when mains power is disconnected
Inventor: KEATS LUTHER
Filed: 2007-04-18
Abstract: A microCHP unit and a method of preventing damage to a microCHP unit upon failure of mains power supply is disclosed. The microCHP unit includes at least one pump and/or fan for circulating a cooling fluid or air through the microCHP unit in normal operation. The microCHP comprises an electric power source that is independent from the mains power supply. A voltage converter, inverter, or both, is connected between the independent power source and the cooling pump(s) and/or fan(s) of the microCHP unit for converting a supply voltage from the independent electric power source to a different voltage for operating the pump(s) and/or fan(s). A controller causes the cooling pump(s) and/or fan(s) to operate in the absence of mains power; and a charging device recharges the independent power source when the mains power supply is available.
Patent NZ-555876-A (NZ)
Title: Production of cloned offspring in a cattle breeding operation
Inventor: STICE STEVEN L
IPC: A01K67/033
Filed: 2003-04-24
Abstract: Disclosed is a method of producing cattle by providing a herd, cloning one of its offspring and replacing the stud or a cow with the clone. The herd is then allowed to continue breeding in order to produce new offspring.
Patent NZ-556340-A (NZ)
Title: Intraparietal reinforcing device for biological cardiac prosthesis and reinforced biological heart valve prosthesis
Inventor: ANDRIEU RAYMOND
Filed: 2005-03-01
Abstract: Provided is an intraparietal reinforcing device adapted to be integrated into a biological valvular prosthesis consisting of a biological cardiac valve in which the valve is composed of a tubular outside wall, three leaflets integral with the tubular outside wall at their outside end and each of the leaflets having essentially triangular and vertical commissures, with the device adapted to be placed inside the organic tissue of this cardiac valve, and consisting of a base and a stabilizing part mounted on the base which is designed to be inserted into the tubular external wall of the cardiac valve and designed to reinforce the structure of the valve in a way to maintain the shape of the cardiac valve after implantation, and wherein the stabilizing part includes at least two intraparietal shafts designed to be inserted into the organic tissue of the cardiac valve, and with these intraparietal shafts positioned on the base in a way that, once the device is in place inside the cardiac valve, they are displaced laterally to the intersection point of the intersection line of the tubular outside wall with the commissurae of the cardiac valve and of the valvular plane of the cardiac valve of the valvular prosthesis.
Patent NZ-561232-A (NZ)
Title: An attachment plate of an spinal disc comprising v-shaped self-tapping fixing ribs
Inventor: KELLER ARNOLD
IPC: A61F2/44
Filed: 2006-06-20
Abstract: An attachment plate forming part of an intervertebral prosthesis that includes two attachment plates is disclosed. The attachment plate comprises an attachment surface with fixing projections. The attachment surface is configured for attachment to an adjacent vertebral body, which has a base surface configured to bear on a endplate of the adjacent vertebral body. The fixing projections rise from the base surface wherein the fixing projections are arranged symmetrically about a medial plane in at least two rows with an interspace opening between the rows. The rows extend outwardly and obliquely in a V-shape with respect to an implantation direction. The fixing projections are configured with a first limit surface formed by a lateral-facing side surface, a second limit surface formed by a medial-facing side surface, a third limit surface formed by a steep ventral-facing surface, and a fourth limit surface formed by an inclined dorsal facing surface. The fixing projections are self tapping and configured to penetrate into the endplate of the adjacent vertebral body.
Patent NZ-574567-A (NZ)
Title: Tracking changing state data to assist in computer network security
Inventor: SINGLA ANURAG
IPC: G06F21/45
Filed: 2007-10-25
Abstract: A computer-implemented method and an apparatus for maintaining state information using a session table to enhance security of a computer network are disclosed. The session table comprises one or more session records and a session record comprises one or more key fields and one or more timestamp fields and one or more value fields. The apparatus comprises a security event module, a query key module, a querying module and a result module. The security event module is configured to identify a security event relating to a possible attack or anomalous behaviour in the computer network. The security event comprises a timestamp and information about operation of a networked device in the computer network. The query key module is configured to determine a query key based on one or more fields of the security event and the querying module is configured to query the session table using the timestamp and the query key. The result module is configured to return a query result relating to state information of the networked device that is valid at the time of the timestamp and from which the possible attack or anomalous behaviour can be investigated.
Patent NZ-576140-A (NZ)
Title: Energy absorbtion device, typically for road vehicle impact, with shell, and void formed by internal wall(s) spanning completely across shell
Inventor: JAMES DALLAS
IPC: E01F15/08
Filed: 2010-04-07
Abstract: An energy absorbing device 501 has a shell with a major axis having at least one external wall defining a closed first internal area. This area is further defined by interior wall(s) spanning opposing sections of the external wall(s). At least one additional internal space in the form of a void is within the first internal area of the shell, such that the additional internal space(s) void(s) span(s) completely across the shell along the major axis. Shown are four internal voids and devices 501, 502, 503, 504 are connected by cables 505, 506 so as to form an assembly 500.
Patent NZ-579200-A (NZ)
Title: Method and arrangement for processing mobile station history information in a wireless communication system
Inventor: MILDH GUNNAR
IPC: H04W24/08
Filed: 2007-12-20
Abstract: A method for processing mobile station transaction information at a serving control node in a wireless communication system and a first control node for use in a wireless communication system are disclosed. The first control node (500) comprises a processing unit (510). The processing unit is configured to receive a transaction history record from a transferring control node in association with a first handover of a mobile station to the first control node; add mobile station transaction data related to the first control node to the transaction history record to obtain an updated transaction history record, by adding a cell identification parameter for the serving control node and one or more of a cell descriptor and one or more time parameters indicating a length of time for which the mobile station was served by the serving control node. The mobile station transaction data is generated by the serving control node. The processing unit is further configured to transfer the updated transaction history record to a target control node in association with a subsequent handover of the mobile station.
Patent NZ-580225-A (NZ)
Title: Nanoparticle comprising rapamycin and albumin as anticancer agent
Inventor: DESAI NEIL P
IPC: A61K9/51
Filed: 2008-03-07
Abstract: Disclosed is the use of a composition comprising nanoparticles that comprise rapamycin or a derivative thereof and a carrier protein (such as nab-rapamycin) in the manufacture of a medicament for treating cancer in an individual, wherein the medicament is formulated for administration at least once every two weeks, wherein the composition to be administered to the individual has an effective amount of rapamycin or the derivative thereof at about 54 mg to about 540 mg.
Patent NZ-580972-A (NZ)
Title: Controlled release pharmaceutical compositions for prolonged effect
Inventor: HEMMINGSEN PERNILLE H YRUP
IPC: A61K9/20
Filed: 2008-06-04
Abstract: Disclosed is a layered pharmaceutical composition comprising A) a solid inner layer comprising i) an active substance, and ii) one or more disintegrants/exploding agents e.g. Sodium starch glycolate, Povidone, Sodium alginate, Alginic acid, Calcium alginate, Carboxymethylcellulose calcium, Carboxymethylcellulose sodium, Powdered cellulose, Chitosan, Croscarmellose sodium, Crospovidone, Hydroxypropyl starch, Hydroxypropyl cellulose, one of more effervescent agents or a mixture e.g. Effer-Soda, Citric acid, Citric acid, monohydrate, Dextrates, Fumaric acid, Potassium bicarbonate, Sodium bicarbonate, Sodium citrate dehydrate,Tartaric acid thereof the solid inner layer being sandwiched between two outer layers B1 ) and B2), each outer layer comprising iii) a substantially water soluble and/or crystalline polymer or a mixture of substantially water soluble and/or crystalline polymers, the polymer being a polyglycol in the form of one of a) a homopolymer having a MW of at least about 100,000 daltons, and b) a copolymer having a MW of at least about 2,000 daltons, or a mixture thereof, and iv) an active substance, which is the same as in said solid inner layer A), and layer A being different from layers B1) and B2), the layered composition being coated with a coating C) that has at least one opening exposing at least one surface of said outer layer, comprising a polymer, and the composition having a cylindrical form, wherein the ratio between the surface area of one end surface of the cylinder and the length of the cylinder is in a range of from 0.02 to 45 mm.
Patent NZ-587332-A (NZ)
Title: Barrier for road with side members interconnected by U-shaped member(s) which do not contact supports holding side members above ground
Inventor: JAMES DALLAS REX
IPC: E01F15/04
Filed: 2011-07-29
Abstract: A barrier 1, for a road or highway, has side W-beam members 3 spaced apart and fixed to supports (not shown) which hold side members 3 above ground. At least one U-shaped member 4 is connected to the opposed side members 3 so as to span between them, and the U-shaped member(s) does (do) not contact the supports. This is stated to provide a strong and lightweight barrier construction.
Patent NZ-590668-A (NZ)
Title: TNF-alpha ANTAGONIST MULTI-TARGET BINDING PROTEINS
Inventor: LOFQUIST ALAN KEITH
IPC: C07K14/715
Filed: 2009-07-02
Abstract: Disclosed is a multi-target fusion protein composed of a TNF-a antagonist domain and another binding domain antagonistic for a heterologous target, such as IL6, RANKL, IL7, IL17A/F, TWEAK, CSF2, IGF1, IGF2 or BLyS/APRIL, or agonistic for a heterologous target, such as IL10. The multi-specific fusion protein includes an intervening domain that separates the binding domains and allows for dimerization. This disclosure also provides polynucleotides encoding the multi-specific fusion proteins, compositions of the fusion proteins, and methods of using the multi-specific fusion proteins and compositions.
Patent NZ-591713-A (NZ)
Title: Solid stable formulations of linaclotide for oral administration
Inventor: FRETZEN ANGELIKA
IPC: A61K9/16
Filed: 2009-08-14
Abstract: ABSTRACT - 591713 The disclosure relates to a solid pharmaceutical composition comprising a pharmaceutically acceptable carrier, linaclotide, a cation selected from Mg2+, Ca2+, Zn2+, Mn2+, K+, Na+ or Al3+ wherein the cation is provided as magnesium chloride, calcium chloride, calcium phosphate, calcium sulfate, zinc acetate, manganese chloride, potassium chloride, sodium chloride or aluminum chloride, and a sterically hindered primary amine, preferably selected from the group consisting of histidine, phenylalanine, alanine, glutamic acid, aspartic acid, glutamine, leucine, methionine, asparagine, tyrosine, threonine, isoleucine, tryptophan and valine.
Patent NZ-592640-A (NZ)
Title: Improved dc bus regulator
Inventor: BOURGEAU EDWARD PETER KENNETH
IPC: H02J3/36
Filed: 2009-10-15
Abstract: An apparatus (600) for interfacing an AC bus and DC bus, comprises a transformer (604) coupled to the AC bus having at least a first output and a second output; a set of one or more transistors (612) coupled to the first output and coupled to the DC bus; a set of one or more diodes (622), separate from the set of one or more transistors, coupled to the second output and coupled to the DC bus; and a microcontroller (613)coupled to the set of one or more transistors configured to regulate the current flow through the set of one or more transistors and to regulate the current flow through the set of one or more diodes. An apparatus for interfacing an AC bus and DC bus, and a method for interfacing a DC bus with a transformer coupled to an AC bus having a set of one or more generators are disclosed. The apparatus comprises a transformer coupled to the AC bus having at least a first output and a second output; a set of one or more transistors coupled to the first output and coupled to the DC bus; a set of one or more SCRs, separate from the set of one or more transistors, coupled to the second output and coupled to the DC bus; and a first microcontroller coupled to the set of one or more transistors configured to regulate the current flow through the set of one or more transistors and to regulate the current flow through the set of one or more SCRs.
Patent NZ-596572-A (NZ)
Title: Nicotine-carrier vaccine formulation
Inventor: LANG RAINER
IPC: A61K39/385
Filed: 2007-05-11
Abstract: 596572 Disclosed is a lyophilised formulation comprising: At least one nicotine-virus-like particle conjugate comprising: A virus-like particle; and At least one nicotine molecule, wherein said at least one nicotine molecule is covalently bound to said virus-like particle by a linking sequence, wherein said linking sequence comprises an ester functionality; and A stabilizer composition comprising: At least one non-reducing disaccharide, wherein the concentration of said non-reducing disaccharide is from 5% to 15% (w/v) in terms of the concentration in the formulation prior to lyophilisation; At least one non-ionic surfactant, wherein the concentration of said non-ionic surfactant is from 0.005% to 0.02% (w/v) in terms of the concentration in the formulation prior to lyophilisation.
Patent NZ-597544-A (NZ)
Title: Modified 4'-nucleosides as antiviral agents
Inventor: DU JINFA
IPC: C12P19/30
Filed: 2006-09-26
Abstract: ABSTRACT - 597544 The disclosure relates to a compound comprising a ?-D- and ?-L-nucleoside e.g. 4'-C-ethynyl-3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof, having a structure defined by formula (I) wherein the variables R1, R2, R3, X, Y and Z are as defined in the specification. These compounds are suitable for the treatment or prophylaxis of a host infected with human immunodeficiency virus (HIV) or hepatitis B virus (HBV).
Patent NZ-597726-A (NZ)
Title: Lashing platform having a magazine for twistlocks
Inventor: KAPELSKI RAINER
IPC: B65D90/00
Filed: 2010-05-26
Abstract: A lashing platform 10 comprising a base frame 20, a setting plate 30 resiliently supported on the base frame 20, a plurality of screwing devices for inserting twistlocks into container fittings or removing twistlocks from container fittings, a plurality of magazines 60 for accommodating the twistlocks, and a plurality of transfer devices for transferring a twistlock from a magazine to a screwing device or from a screwing device to a magazine 60, the lashing platform being characterized by at least two units, which are each formed by at least two screwing devices , at least one transfer device , and at least one magazine 60 and which can be moved relative to each other in the longitudinal direction of the lashing platform 10 within the base frame 20, at least one drive for moving the units, and a controller for moving the units into positions in which the screwing devices have access to the container fittings of containers of different size.
Patent NZ-600757-A (NZ)
Title: Track for a track bound vehicle
Inventor: VOLLENWYDER KURT
IPC: B60L5/00
Filed: 2010-12-21
Abstract: 600757 Disclosed is an arrangement and method for building a track for track bound vehicles, in particular for light rail vehicles. The prefabricated track module disclosed reduces construction work and time required on site of construction. The arrangement comprises of a support element (304), an electrically conductive shield (355) and a housing or cavity (21). The support device (304) supports an electric conductor arrangement. The electric conductor arrangement is adapted to produce an alternating electromagnetic field to transfer electromagnetic energy to vehicles on the track. The support element (304) confines spaces for receiving lines and/or wires of the conductor arrangement. The electrically conductive shield (355) shields the alternating electromagnetic field. The shield (355) extends along a plane below the spaces. The housing or cavity (21) receives a power supply device (31) which supplies electric power to the conductor arrangement. The support element (304), the electrically conductive shield (355) and the housing or cavity (21) form a pre-fabricated track module.
Patent NZ-608649-A (NZ)
Title: Ionophore antibiotic suspension
Inventor: SILVA JEREMY
IPC: A61P31/04
Filed: 2012-03-26
Abstract: Disclosed herein is an alcohol based suspension formulation including sodium monensin in an organic liquid phase including at least one polyol, and benzyl alcohol; and at least one anionic and/or non-ionic surfactant; at least one stabilising agent; and water. Additionally disclosed is a method of manufacturing the alcohol based suspension formulation the method including the steps of: (a) wetting and mixing the ionophore antibiotic with benzyl alcohol and surfactant; and (b) adding water and/or at least one stabilising agent to the mixture of step (a); and (c) adding at least one polyol to volume to the mixture of step (b). The formulation is useful in the treatment of bloat, ketosis, coccidiosis and enhancing the milk production from a lactating animal.
Patent NZ-624206-A (NZ)
Title: R(+)-n-formyl-propargyl-aminoindan
Inventor: SAFADI MUHAMMAD
IPC: C07C233/03
Filed: 2012-10-09
Abstract: Disclosed is R (+)-N-formyl-propargyl-aminoindan, and a process for preparing R(+)-N-formyl-propargyl-aminoindan comprising the steps of: e) mixing R-(+)-N-Propargyl-1-aminoindan (rasagiline) with formic acid in a first solvent such as acetic anhydride at a temperature of less than 30°C; f) evaporating the first solvent to obtain an oil; g) dissolving the oil in a second solvent such as ethyl acetate to form a solution; and h) isolating and obtaining R(+)-N-formyl-propargylaminoindan from the solution.
Patent NZ-631098-A (NZ)
Title: Anti-hepcidin antibodies and uses thereof
Inventor: HUILING HAN
IPC: C07K16/00
Filed: 2014-03-13
Abstract: Disclosed is an antibody, or antigen-binding fragment thereof, that specifically binds to hepcidin or a hepcidin peptide, comprising a heavy chain variable region and a light chain variable region as defined in the complete specification.
Patent NZ-700561-A (NZ)
Title: Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
Inventor: DE VISSER PETER CHRISTIAN
IPC: C12N15/113
Filed: 2013-04-23
Abstract: The current invention provides an improved oligonucleotide consisting of a 2’-O-methyl RNA nucleotide residue, having a backbone wherein all phosphate moieties are replaced by phosphorothioate moieties, having a base sequence consisting of (XYG)7 wherein each X is 5-methylcytosine and each Y is Uracil and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
Patent NZ-709744-A (NZ)
Title: Mixed disulfide conjugates of thienopyridine compounds and uses thereof
Inventor: ZHANG HAOMING
IPC: C07D405/12
Filed: 2014-01-06
Abstract: The invention relates to a class of compounds of Formula I, including their pharmaceutically acceptable salts, solvates and/or prodrugs thereof, that prevent polymorphic cytochrome P450 mediated oxidative bioactivation, and the use of such compounds as therapeutics for the treatment, amelioration, and prevention of cardiovascular diseases.
Patent NZ-711201-A (NZ)
Title: Enteric coated tablet
Inventor: RYU AKIO
IPC: A61P1/04
Filed: 2014-02-21
Abstract: Provided is an enteric coated tablet that has a large amount of a drug component and that has sufficient impact strength without having to make the enteric coating film thick. The enteric coated tablet has the following: (A) a drug component-containing plain tablet weighing 1,000 mg or more; on the surface of the plain tablet, (B) a water-soluble polymer-containing coating film; and on the surface of the water-soluble polymer-containing coating film, (C) an enteric coating film that dissolves at a pH of 7 or higher. The enteric coated tablet is characterized in that the total amount of coating film (B) and coating film (C) is 10-18 mg/cm2, coating film (B) is 6-12 mg/cm2, and coating film (C) is 3-6 mg/cm2.